RxDoctor Payments Data

Tom Kirkwood, MD

Family Medicine · Bicknell, INNPI 1801894621

Payments from drug & device makers

$1,020in general payments, 2019–2025

Across 70 payments — averaging $14.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$207
  • Pfizer$132
  • Amgen$101
  • GSK$87
  • Novartis$77
  • Eisai Inc.$73
  • plus $344 from 10 others

What the payments were for

  • Food & beverage$1,020100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,020 in reported general payments places this provider in the 60th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$187,082
Medicare patients
465
Services billed
2,381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban241$175,355
OzempicSemaglutide142$135,266
JardianceEmpagliflozin159$133,371
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$43,655
XareltoRivaroxaban40$40,633
JanuviaSitagliptin Phosphate42$36,764
EntrestoSacubitril/Valsartan54$34,697
TrulicityDulaglutide15$23,272
FarxigaDapagliflozin Propanediol31$19,284
Tresiba Flextouch U-100Insulin Degludec24$17,563
Repatha SureclickEvolocumab25$14,420
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$11,095
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$9,524
Lantus SolostarInsulin Glargine,hum.Rec.Anlog59$9,166
Humalog Kwikpen U-100Insulin Lispro42$8,752

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$132$175,355241 claims
Novo NordiskOzempic$207$135,266142 claims
GSKTrelegy Ellipta, Breo Ellipta$87$48,77772 claims
MerckJanuvia$58$36,76442 claims
NovartisEntresto$77$34,69754 claims
Lilly USA, LLCTrulicity$39$23,27215 claims
AstraZenecaFarxiga$22$19,28431 claims
Astellas Pharma US IncMyrbetriq$60$8,67214 claims
AbbVieSynthroid$38$2,01054 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Bicknell

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →